Literature DB >> 1694254

Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma.

R O Schlingemann1, F J Rietveld, R M de Waal, N J Bradley, A I Skene, A J Davies, M F Greaves, J Denekamp, D J Ruiter.   

Abstract

It has been reported that the human haemopoietic progenitor cell antigen CD34 is also expressed by vascular structures. To investigate its precise vascular localization, we have studied the cellular and subcellular distribution of CD34 in normal tissues and pathologic tissues with neovascularization. In normal resting tissues, anti-CD34 antibodies, ICH3 and QBEND-10 predominantly stain the luminal endothelial membrane, whereas the abluminal membrane is negative or weakly positive. In contrast, a striking staining of endothelial abluminal microprocesses (EAM) was found in the tumor stroma. These structures, measuring up to 20 microns in length, could be observed in thick vibratome sections both at the tips of vascular sprouts and, also frequently, on fully formed microvessels. The number of vascular sprouts and EAM varied widely between different tumors. CD34-stained EAM were sparsely present in fetal tissue of 10 weeks gestation, but they could not be demonstrated in granulation tissue of wound healing. By immunoelectron microscopy, the EAM were continuous with the cytoplasm of endothelial cells showing an immature phenotype as seen in regeneration. In cultured human umbilical vein endothelium, CD34 was preferentially found on a small subset of cells with the morphologic appearance of migrating cells. These findings suggest that CD34 is an endothelial marker for EAM present during angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694254

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  51 in total

1.  Temporary amniotic membrane patch for the treatment of primary pterygium: mechanisms of reducing the recurrence rate.

Authors:  Juan Ye; Koung Hoon Kook; Ke Yao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-17       Impact factor: 3.117

2.  Towards the phenotyping of soft tissue tumours by cell surface molecules.

Authors:  G Mechtersheimer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  CD antigens as promising tools for the functional analysis of solid tumours.

Authors:  P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  Neoplastic transformation and angiogenesis in the thymus of transgenic mice expressing SV40 T and t antigen under an L-pyruvate kinase promoter (SV12 mice).

Authors:  Bernadette Nabarra; Christiane Pontoux; Cecile Godard; Mary Osborne-Pellegrin; Sophie Ezine
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

5.  Immunohistochemical evidence for the heterogeneity of maternal and fetal vascular endothelial cells in human full-term placenta.

Authors:  I Lang; M Hartmann; A Blaschitz; G Dohr; G Skofitsch; G Desoye
Journal:  Cell Tissue Res       Date:  1993-11       Impact factor: 5.249

Review 6.  Tumor vascular endothelium: barrier or target in tumor directed drug delivery and immunotherapy.

Authors:  G Molema; L F de Leij; D K Meijer
Journal:  Pharm Res       Date:  1997-01       Impact factor: 4.200

7.  Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas.

Authors:  E Poblet; F Gonzalez-Palacios; F J Jimenez
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

8.  Inducible expression of MS-1 high-molecular-weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro.

Authors:  S Goerdt; R Bhardwaj; C Sorg
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

9.  Progenitor cells in healing after pterygium excision.

Authors:  Jeong Kyu Lee; Jae Chan Kim
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

10.  Microvessel density and clinicopathologic characteristics in hepatocellular carcinoma with and without cirrhosis.

Authors:  Ivan Chebib; Meer Taher Shabani-Rad; Michelle S Chow; James Zhang; Zu-Hua Gao
Journal:  Biomark Insights       Date:  2007-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.